Skip to content

Demonstration experiment on improving communication with patients using ePRO in atopic dermatitis

Demonstration experiment on improving communication with patients using ePRO in atopic dermatitis - Demonstration experiment on improving communication with patients using ePRO in atopic dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050076
Enrollment
20
Registered
2023-01-25
Start date
2023-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

The ePRO system uses Integrity Healthcare&#39
s YaDoc. After obtaining consent for participation in this study from the research subject patient, install the application on the smartphone owned by the research subject according to the YaDoc opera
s photography function. The recording period shall be 8 weeks. Before the start and at the end of the study, a questionnaire survey will be conducted on the research subjects to examine the usefulness

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1 Patients with atopic dermatitis who are 18 years of age or older at the time of informed consent 2 Patients judged by the investigator that patient data collection by ePRO is effective 3 Smartphone (iOS, Android) users

Exclusion criteria

Exclusion criteria: 1 Cases where it is difficult to see, operate, and understand YaDoc and smartphones 2 Patients participating in a clinical study with other interventions at the start of this study 3 Other patients who are judged by doctors to be unfavorable subjects

Design outcomes

Primary

MeasureTime frame
Patients' satisfaction and challenges with using ePRO will be assessed using patient questionnaires at the beginning and after 8 weeks.

Countries

Japan

Contacts

Public ContactMotoi Takenaka

Nagasaki University Hospital Dermatology and Allergology

m-take@nagasaki-u.ac.jp0958197200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026